Lifestyle

K-Sunscreen 'Well-Received' in Japan… Gungjung Bibcha Expands Sun Care Portfolio

KIM JUNG YOU
2026-06-24 08:57:18
[Edaily Reporter KIM JUNG YOU ] Zero to Seven Inc(159580)announced on the 24th that its infant and toddler cosmetics (beauty) brand, “Gungjung Bibchaek,” has recently significantly expanded its sun care product lineup in the Japanese market.
Photo: Zero to Seven
Inc

During this month’s “Qoo10 MegaWari”—Japan’s largest e-commerce discount event—Gungjung Bibchaek’s sun care product line accounted for 69% of total sales. Three flagship products—the “Moisture Sun Stick Mild,” “Moisture Sun Cushion Mild,” and “Waterful Sun Lotion Mild”—led the sales.

Gungjung Bibchaek’s sales during this Mega Wari event increased by approximately 600% compared to its total sales last month. In addition to Qoo10 Japan, Gungjung Bibchaek is expanding its sales through major e-commerce channels such as Amazon Japan.

A company representative stated, “With the recent surge in interest in K-Beauty in the Japanese market, Gungjung Bibchaek’s sun care products and baby line are also receiving a positive response,” adding, “We plan to continue growing into a brand trusted by Japanese consumers based on our expertise and safety standards for infants, toddlers, and those with sensitive skin.”

Economy

Corporation

IT·Science

Economy

[Exclusive] Jeonbuk Bank Launches First Bitcoin-Linked Loan in the Domestic Banking Sector

Jeonbuk Bank, a subsidiary of JB Financial Group Co., Ltd.(175330), has become the first bank in South Korea to introduce won-denominated loans linked to digital assets. Initially, the service will be…
2026-10-12 09:35:03

Corporation

GENINUS Inc. Begins Experimental Validation of New Anti-Cancer Drug Target Identified by AI… 'Lays Groundwork for Technology Transfer'

GENINUS Inc.(389030)is embarking on experimental research to verify the feasibility of developing actual treatments based on new anti-cancer drug targets identified using artificial intelligence (AI).…
2026-10-12 08:01:02

IT·Science

Onconic Therapeutics Inc. Unveils 'OCN-501,' a New GLP-1 Combination Therapy for Obesity, for the First Time

#Onconic Therapeutics Inc. has unveiled a new drug candidate designed to reduce muscle loss that can occur during weight loss when used in combination with existing glucagon-like peptide-1 (GLP-1) cla…
2026-10-12 09:27:02